Endonovo Reports Positive Results in Critical Limb Ischemia Study Using Non-Invasive Medical Device
February 12, 2018 09:32 ET
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive wearable Electroceutical™...
Endonovo Reports Pre-Clinical Data Demonstrating Immunotronics™ Reduced Infarct Size and Inhibited Fibrosis following Myocardial Infarction
February 01, 2018 09:32 ET
|
Endonovo Therapeutics, Inc.
LOS ANGELES, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive wearable Electroceutical™...
Endonovo Announces First Commercial Sales for SofPulse Wearable Electroceutical for Post-Operative Pain and Edema
January 22, 2018 07:00 ET
|
Endonovo Therapeutics, Inc.
Seeking Distribution Partners in Europe for CE-Marked Electroceutical™ Device for Promotion of Wound Healing, Reduction of Pain and Post-Operative Edema LOS ANGELES, CA, Jan. 22, 2018 (GLOBE...
Endonovo Therapeutics Provides Corporate Update and 2018 Outlook
January 16, 2018 09:35 ET
|
Endonovo Therapeutics, Inc.
- Announces Series C Preferred Stock Offering - Updates Status of Clinical Pipeline in Central Nervous System Disorders LOS ANGELES, CA, Jan. 16, 2018 (GLOBE NEWSWIRE) -- - Endonovo...
Endonovo Therapeutics Engages ShareIntel, A Leader In Shareholder Intelligence Services To Investigate Market Maker and Clearing Firm Irregularities
January 11, 2018 09:00 ET
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA, Jan. 11, 2018 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a clinical-stage developer of non-invasive electroceuticals for the...
Endonovo Therapeutics Provides Update on Acquisition of PEMF Assets, Clinical Pipeline and Pre-Clinical Study
December 28, 2017 09:30 ET
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA, Dec. 28, 2017 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a clinical-stage developer of non-invasive electroceuticals for the...
Endonovo Therapeutics Acquires Assets of Electroceuticals Developer, Rio Grande Neurosciences, and Settles Lawsuit
December 26, 2017 07:30 ET
|
Endonovo Therapeutics, Inc.
Endonovo to Fund All Currently Planned and Future Clinical Trials for Traumatic Brain Injury, Post-Concussion Syndrome, Stroke and Other Central Nervous System Disorders LOS ANGELES, CA, Dec. ...
Endonovo Therapeutics Files Continuation Patent for Producing Adult Stem Cell Secretome
June 29, 2016 09:32 ET
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA--(Marketwired - Jun 29, 2016) - Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a developer of bioelectronic devices and medicines, announced today that it...
Endonovo Therapeutics Receives Final Commissioned Report Recommendations Regarding FDA Regulatory Pathway for Urinary Incontinence Treatment
December 02, 2014 09:00 ET
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA--(Marketwired - Dec 2, 2014) - Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a biotechnology company developing innovative regenerative therapies, has...
Endonovo Therapeutics Files Patent on Bioelectronic Technology, Devices and Therapies
September 02, 2014 09:00 ET
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA--(Marketwired - Sep 2, 2014) - Endonovo Therapeutics, Inc. (OTCQB: ENDV), a developer of novel cell-free therapies, announced today that it has filed a patent on bioelectronic...